Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of US$ 17 million for twelve months ending June 2020 ... Oct 21
ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical ... Oct 21
Zydus Cadila has received final approval from the USFDA to market Solifenacin Succinate Tablets, in the strengths of 5 mg and 10 mg... Oct 21
Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
-Advertisements-